Wednesday 6 December 2017

Infertility treatment Market 2023 New Research Study

The global infertility treatment market is anticipated to garner majority of the market during the forecast period owing to factors like increasing private-public investments, fertility rates, funds and grants and funds, increasing public awareness pertaining to infertility and the available treatment options, the increasing number of fertility clinics across the world and enhanced technology in fertility treatment are the major market driving factors for the growth of this market.


Depending on procedure, the infertility treatment market is sectioned into artificial insemination (AI), assisted reproductive technology(ART),fertility surgeries, and several other procedures. Of which, in 2016, ART segment attributes for the biggest market share of this industry due to escalating cases of infertility and increasing occurrence of lifestyle related disorders, enhanced technology in IVF field, more number of adoption of methods such as surrogacy and superior success rate of ART procedures.
Based on product, the infertility treatment market is segmented into media & consumables, instruments, and accessories. In 2016, the instruments segment was responsible for the biggest share in the market. Under instruments segment, the imaging systems product segment was the largest in 2016 due to increased usage of imaging systems in many procedures.
Hospitals and clinics, fertility centers, research institutes and cryobanks are various branches of the end user segment of this market on a global market.
Geographically, North America was leading in 2016, followed by Europe. Nevertheless, Asia Pacific region is predicted to propel at the most rapid CAGR since countries such as India, China, Taiwan, and Korea etc., are predicted to render superior growth opportunities for several market players.
The major market manufacturers of the global infertility treatment market are Irvine Scientific, Esco Micro Pte. Ltd, IVFtech ApS, The Baker Company Inc, Thermo Fisher Scientific Inc, Vitrolife AB, Cook Group Incorporated and Genea Limited.


No comments:

Post a Comment